GlassScriptPhysician profile
Karen Klugo
NPI 1306833496
$16,890.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $2,633 · 2021: $8,694 · 2022: $5,189 · 2023: $158 · 2024: $34.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16,124.78 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $211.97 | 2019-2024 | Cequa |
| Alcon Vision LLC | $139.37 | 2020-2023 | Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $112.79 | 2021-2023 | |
| Allergan, INC. | $81.51 | 2019-2021 | |
| Abbvie INC. | $73.71 | 2022-2023 | |
| Biotissue Holdings INC. | $36.15 | 2022 | |
| Kala Pharmaceuticals, INC. | $34.17 | 2021-2022 | |
| Shire North American Group INC | $28.55 | 2019 | |
| Aerie Pharmaceuticals, INC. | $18.57 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $16.09 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $12.94 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Klugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.